Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Obstet Gynecol. 2011 Oct;118(4):831–839. doi: 10.1097/AOG.0b013e31821a0f4d

Fig. 1.

Fig. 1

Cumulative risk of genital warts among human immunodeficiency virus (HIV) seropositive and seronegative women in the original cohort. P < .001 for differences between groups across all visits.